Bioethics, Ltd.
BOTH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $123 | $44 | $47 | $59 |
| SG&A Expenses | $123 | $50 | $47 | $59 |
| Sales & Mktg Exp. | $0 | $6 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $123 | $50 | $47 | $59 |
| Operating Income | -$123 | -$50 | -$47 | -$59 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$54 | -$47 | -$46 | -$48 |
| Pre-Tax Income | -$177 | -$97 | -$93 | -$107 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$177 | -$97 | -$93 | -$107 |
| % Margin | – | – | – | – |
| EPS | -0.12 | -0.086 | -0.082 | -0.094 |
| % Growth | -40.2% | -4.3% | 13% | – |
| EPS Diluted | -0.12 | -0.086 | -0.082 | -0.094 |
| Weighted Avg Shares Out | 1,493 | 1,135 | 1,135 | 1,135 |
| Weighted Avg Shares Out Dil | 1,493 | 1,135 | 1,135 | 1,135 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $54 | $47 | $46 | $48 |
| Depreciation & Amortization | $0 | $50 | $0 | $0 |
| EBITDA | -$123 | $0 | -$47 | -$59 |
| % Margin | – | – | – | – |